Drug Development for Neurodegenerative Diseases April 6, 2009

At this Marcus Evans event, you will hear from market leaders on how to plan a phase III trial to prove efficacy of both symptomatic and disease modifying drugs, utilize alternative trial models to decrease time to market and dollars spent.

Official Website: http://www.marcusevans.com/html/eventdetail.asp?eventID=15280&SectorID=31&divisionID=